Status:

COMPLETED

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis

Lead Sponsor:

Merck KGaA, Darmstadt, Germany

Conditions:

Multiple Sclerosis, Relapsing-Remitting

Eligibility:

All Genders

18-55 years

Brief Summary

The Canadian Multiple Sclerosis Working Group (CMSWG) has developed practical recommendations on how neurologists can assess the status of subjects on disease modifying drugs (DMDs) and decide when it...

Detailed Description

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) and is one of the most common causes of neurological disability in young adults. The neuro...

Eligibility Criteria

Inclusion

  • Subjects with duration of RRMS or CIS ≤ 10 yr from onset of symptoms.
  • Subjects aged between 18 and 55 years
  • Subjects with EDSS score of 0 to ≤ 4.0
  • Subjects on consistent therapy with a single DMD (Avonex®, Betaseron®, Copaxone®, Rebif®) for at least 12 months.
  • Subjects whose relapse data over the last 12 months was available in the subject's chart
  • Subjects whose EDSS data over the last 12 months was available in the subject's chart
  • Subjects who were eligible to receive any of the 4 DMDs
  • Consecutive subjects were screened until 10 eligible subjects were enrolled (to minimize any selection bias) - Subject was therefore one of 10 consecutive eligible, consenting subjects
  • Subjects who had given written informed consent with the understanding that the subject could withdraw consent at any time without prejudice to future medical care

Exclusion

  • Subject who was not expected to be followed reliably over the next 12 months
  • Subjects with concomitant participation in any other studies involving investigational or marketed products
  • Subject wo had previously failed DMD therapy and/or switched between therapies

Key Trial Info

Start Date :

July 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

192 Patients enrolled

Trial Details

Trial ID

NCT01142583

Start Date

July 1 2006

End Date

August 1 2009

Last Update

March 18 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.